Compare Hims and Hers Health Inc (HIMS) vs iShares Russell 2000 ETF (IWM) Price & Performance

Hims & Hers Health trades at $32.70, down 0.43% on the day, with a mixed technical picture showing bullish moving averages but neutral oscillators. Fundamentally, the company reported 2025 revenue of $2.35 billion and net income of $128.37 million, though 2026 projections indicate a net loss. Recent news highlights executive departures and anticipation for Q2 2026 earnings on August 10, 2026.

The investment outlook is cautiously optimistic, supported by a 35% analyst buy rating and a $33.57 consensus price target. Key opportunities include growth in the weight-loss drug segment and international expansion. Risks involve profitability volatility, intense competition, and reliance on telehealth regulatory frameworks. The stock's valuation remains elevated with a P/E of 57.14, demanding strong future earnings growth to justify current levels.

IWM, tracking the Russell 2000 small-cap index, trades at $292.34, down 0.6% on the day. Technical indicators show a bullish bias with moving averages supporting an uptrend, while oscillators are neutral. Recent news highlights strong small-cap outperformance, with the Russell 2000 up approximately 20% year-to-date, fueled by institutional inflows and a shifting interest rate outlook.

The outlook for IWM is positive, driven by potential for continued small-cap leadership amid economic expansion and lower rate expectations. Key risks include higher volatility relative to large-caps and sensitivity to broader economic conditions. The ETF offers diversified exposure to nearly 2,000 small-cap stocks, but investors should weigh its 0.19% expense ratio against alternatives.